Market Place
Sourcing Support
All News #Library
Biotech
COUR Reports Positive One-Year Phase 2A Results for CNP-104
03 Mar 2026 //
GLOBENEWSWIRE
COUR Pharma Publishes Peer-Reviewed Data In Science Advances
28 Jan 2026 //
GLOBENEWSWIRE
COUR Pharma Begins Trial of CNP-103 in Type 1 Diabetes
19 Aug 2025 //
GLOBENEWSWIRE
COUR Pharma Secures FDA Clearance for CNP-103 in Type 1 Diabetes
04 Feb 2025 //
GLOBENEWSWIRE
COUR Signs Licensing Deal with Genentech for Autoimmune Therapy
03 Dec 2024 //
GLOBENEWSWIRE
COUR Pharmaceuticals Doses First Patient in Myasthenia Trial
30 Oct 2024 //
GLOBENEWSWIRE
COUR Pharmaceuticals Presents Phase 2a Data For CNP-104
21 Oct 2024 //
GLOBENEWSWIRE
COUR Pharmaceuticals Announces Leadership Transition
01 Aug 2024 //
GLOBENEWSWIRE
COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer
19 Jul 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.